PRF for Treating Maxillary Gingival Recession
Primary Purpose
Gingival Recession
Status
Completed
Phase
Not Applicable
Locations
Palestinian Territory, occupied
Study Type
Interventional
Intervention
Gingival coverage using coronally advanced flap and a connective tissue graft
Gingival coverage using coronally advanced flap and platelet rich fibrin membranes
Sponsored by
About this trial
This is an interventional treatment trial for Gingival Recession focused on measuring connective tissue graft, PRF membrane, gingival recession
Eligibility Criteria
Inclusion Criteria:
- Greater than 18 years old
- Bilateral Miller class I + II recession in the upper jaw
Exclusion Criteria:
- Smokers
- Patients with systemic diseases that could interfere with the healing
- Patients undergoing bisphosphonate therap .Patients who previously received radiation therapy of the jaws.
Sites / Locations
- Arab American University
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
coronally advanced flap with connective tissue graft
coronally advanced flap with platelet rich fibrin membranes
Arm Description
After randomization a subepithelial connective tissue graft along with coronally advanced flap is applied to one maxillary quadrant to cover the recession.
After randomization platelet rich fibrin membranes along with coronally advanced flap are applied to the other maxillary quadrant to cover the recession.
Outcomes
Primary Outcome Measures
Increase in gingival height (recession coverage)
The measurements of the increase in gingival height (recession coverage) using a linear evaluation (corono-apical direction) with a periodontal probe (Merrit-B; Hu-Friedy, Chicago, IL, USA) at the interventions sites to the nearest 0.5 mm. Registration of the recession height was done before treatment and after 6 weeks.
Shrinkage in gingival height
To assess the shrinkage of the gingival height, the amount of gingival height vestibular to the treated teeth in a corono-apical direction was measured after the surgery and after six months.
Secondary Outcome Measures
Postoperative pain visual analog scores (VAS) and surgery time
This questionnaire used 100 mm visual analog scores VAS to evaluate the amount of pain, ranging from 0 (no pain) to 10 (worst pain imaginable), and the amount of swelling. Patients were asked to fill in the VAS scales at day 7 and day 14 at suture removal. The time of surgery was measured of both treatment options. Timing started at the moment of first incision until the last suture.
Full Information
NCT ID
NCT05267015
First Posted
February 14, 2022
Last Updated
February 23, 2022
Sponsor
Arab American University (Palestine)
1. Study Identification
Unique Protocol Identification Number
NCT05267015
Brief Title
PRF for Treating Maxillary Gingival Recession
Official Title
PRF for Treating Maxillary Gingival Recessions: A Split-mouth, Randomized, Controlled Clinical Trial
Study Type
Interventional
2. Study Status
Record Verification Date
February 2022
Overall Recruitment Status
Completed
Study Start Date
January 3, 2021 (Actual)
Primary Completion Date
August 15, 2021 (Actual)
Study Completion Date
November 14, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Arab American University (Palestine)
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This is a split-mouth, randomized, controlled clinical trial that aims to evaluate the clinical efficacy of platelet-rich fibrin (PRF) membranes in conjunction with coronally advanced flap (CAF) in treating maxillary gingival recession defects.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gingival Recession
Keywords
connective tissue graft, PRF membrane, gingival recession
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
15 (Actual)
8. Arms, Groups, and Interventions
Arm Title
coronally advanced flap with connective tissue graft
Arm Type
Active Comparator
Arm Description
After randomization a subepithelial connective tissue graft along with coronally advanced flap is applied to one maxillary quadrant to cover the recession.
Arm Title
coronally advanced flap with platelet rich fibrin membranes
Arm Type
Experimental
Arm Description
After randomization platelet rich fibrin membranes along with coronally advanced flap are applied to the other maxillary quadrant to cover the recession.
Intervention Type
Procedure
Intervention Name(s)
Gingival coverage using coronally advanced flap and a connective tissue graft
Intervention Description
A coronally advanced flap is applied for recession coverage in the maxilla in a split-mouth randomized trial using a subepithelial connective tissue graft
Intervention Type
Procedure
Intervention Name(s)
Gingival coverage using coronally advanced flap and platelet rich fibrin membranes
Intervention Description
A coronally advanced flap is applied for recession coverage in the maxilla in a split-mouth randomized trial using platelet rich fibrin membranes
Primary Outcome Measure Information:
Title
Increase in gingival height (recession coverage)
Description
The measurements of the increase in gingival height (recession coverage) using a linear evaluation (corono-apical direction) with a periodontal probe (Merrit-B; Hu-Friedy, Chicago, IL, USA) at the interventions sites to the nearest 0.5 mm. Registration of the recession height was done before treatment and after 6 weeks.
Time Frame
six weeks
Title
Shrinkage in gingival height
Description
To assess the shrinkage of the gingival height, the amount of gingival height vestibular to the treated teeth in a corono-apical direction was measured after the surgery and after six months.
Time Frame
six months
Secondary Outcome Measure Information:
Title
Postoperative pain visual analog scores (VAS) and surgery time
Description
This questionnaire used 100 mm visual analog scores VAS to evaluate the amount of pain, ranging from 0 (no pain) to 10 (worst pain imaginable), and the amount of swelling. Patients were asked to fill in the VAS scales at day 7 and day 14 at suture removal. The time of surgery was measured of both treatment options. Timing started at the moment of first incision until the last suture.
Time Frame
two weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Greater than 18 years old
Bilateral Miller class I + II recession in the upper jaw
Exclusion Criteria:
Smokers
Patients with systemic diseases that could interfere with the healing
Patients undergoing bisphosphonate therap .Patients who previously received radiation therapy of the jaws.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mahmoud F Abu-Ta'a, Periodontist
Organizational Affiliation
Head of Department
Official's Role
Principal Investigator
Facility Information:
Facility Name
Arab American University
City
Ramallah
ZIP/Postal Code
240
Country
Palestinian Territory, occupied
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
PRF for Treating Maxillary Gingival Recession
We'll reach out to this number within 24 hrs